Navigation Links
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
Date:7/6/2008

BD GeneOhm(TM) Cdiff Assay Submitted for FDA Clearance

SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the CE marking of the BD GeneOhm(TM) Cdiff molecular assay for the rapid diagnosis of patients with Clostridium difficile infection (CDI). It is the first CDI diagnostic test that offers sensitivity, simplicity and speed in one test procedure. BD has also submitted this assay to the U.S. Food and Drug Administration for clearance.

CE marked under the European In Vitro Diagnostics Directive for the identification of toxigenic Clostridium difficile directly from stool specimens, the BD GeneOhm Cdiff assay targets the toxin B gene, found in toxigenic Clostriduim difficile strains. It is the only CDI diagnostic test that combines high assay sensitivity with a rapid turnaround time of less than two hours, facilitating earlier appropriate treatment of patients suffering from CDI and earlier implementation of infection control interventions to prevent transmission of Clostridium difficile to other patients. Until now, rapid diagnosis of CDI has been difficult since traditional methods consist of immunoassays, which lack sufficient sensitivity, and traditional "gold standard" tissue culture cytotoxicity methods, which are difficult to perform and require several days to yield results.

"The BD GeneOhm Cdiff assay provides a simple and rapid stool test with excellent sensitivity and specificity that allows same-day identification of toxigenic Clostridium difficile," said Thomas Davis, M.D., Ph.D., Professor, Pathology and Laboratory Medicine, Clarian Pathology Laboratory. "This test should improve patient care because it effectively
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... NEW YORK , July 7, 2015 /PRNewswire/ ... Welch Allyn for $2 billion in cash and ... competitive patient monitoring market, according to Kalorama Information. ... heretofore participated in the medical device and advanced ... maker of hospital beds, patient lifting devices, and ...
(Date:7/7/2015)... 7, 2015 According to ... Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, ... Alpha Emitters, Brachytherapy - Y-90), by Application (Oncology, ... by MarketsandMarkets, this report studies the global Nuclear ... to 2020. This market is expected to reach ...
(Date:7/7/2015)... July 7, 2015 A power morcellator lawsuit ... been settled for an undisclosed amount, Bernstein Liebhard LLP ... in March 2014 in the U.S. District Court, Eastern ... of a widower whose wife had died in February ... hysterectomy that involved the use of a power morcellator. ...
Breaking Medicine Technology:Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 2Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 2Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 4Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3
... 2011 Today, Osseon® Therapeutics, Inc. launched the ... in Osseon,s suite of minimally invasive products for ... (Photo:   http://photos.prnewswire.com/prnh/20110901/SF61461 ) The Osseoflex ... vertebral body. The Osseoplasty™ procedure offers unparalleled flexibility ...
... N.Y., Sept. 1, 2011 Polar ( www.polarusa.com ), ... technologies, today introduced the Polar Move . The ... needs of the education market. Its introduction solidifies Polar ... building on the success of schools who have used ...
Cached Medicine Technology:Osseon® Announces Commercial Release of Osseoflex®SN (Steerable Needle) 2New Polar Move Heart Rate Monitor for Students Facilitates Effective and Safe Physical Education 2New Polar Move Heart Rate Monitor for Students Facilitates Effective and Safe Physical Education 3New Polar Move Heart Rate Monitor for Students Facilitates Effective and Safe Physical Education 4
(Date:7/7/2015)... Garden City, NY (PRWEB) , ... July 08, ... ... (NAPW) honors Jessica Goldstein as a 2015-2016 inductee into its ... for leadership in business. NAPW is the nation’s leading networking organization exclusively for ...
(Date:7/7/2015)... ... July 07, 2015 , ... sweetFrog Enterprises, LLC has announced the opening of its newest store ... in the Buckeye State. The premium frozen yogurt chain was listed as #22 on ... located at 3259 Maple Avenue, Zanesville, OH 43701. , “We are thrilled to finally ...
(Date:7/7/2015)... ... 2015 , ... U.S. Rep. Mike Thompson (D-CA 5) introduced ... services available to Medicare beneficiaries. Thompson’s bill, the Medicare Telehealth Parity Act, was ... 6) and Peter Welch (D-VT). , “This bi-partisan legislation takes an important step ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... everyday items, recently launched their first line of luxury smart jewelry called the ... is expected to ship this fall. , “The Socialite collection was crafted ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... stores throughout the Southwest, including Giant, Mustang, Sun Dial and Howdy’s, raised ... surpassing their original 2015 fundraising goal by nearly $100,000, to help support ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Jessica Goldstein, Vice President / Account Director at Discovery USA, Into its VIP Woman of the Year Circle 2Health News:sweetFrog Grows in Ohio with New Store Opening 2Health News:The American Telemedicine Association Supports Legislation to Expand Medicare Coverage for Telemedicine Services 2Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3
... of Mental Health currently conducting a study regarding Cognitive Behavioral Therapy as ... where unhealthy weight loss is developing into a crisis. BDD is ... OCD. Dr. Allison Conner provides thoughts on the study. , ... ...
... on Aug. 3 of increased new infections in 2006,follows ... 1 The new HIV infection,figures scheduled to be ... Disease,Control and Prevention (CDC) are expected to increase the ... significantly more. Though the agency,says the one-year revision does ...
... KNSY ) today announced that it will release ... ended June 30, 2008 at 7:00 A.M.,Eastern Time on ... CEO, will be hosting a teleconference,discussing the earnings results ... To participate in the teleconference call, dial 612-332-0345. ...
... GXDX ), a specialized laboratory services provider, announced the,election ... its Board of,Directors, effective as of July 30, 2008. ... I director of Genoptix until the 2011 Annual Meeting ... of the Board of,Directors. Dr. McCarthy has been elected ...
... most aggressive types of brain tumor, have an extremely ... group of proteins known as receptor tyrosine kinases (RTKs) ... RTK inhibitors have met with limited clinical success ... treatment and most subsequently relapse after only a short ...
... & Balances, a unique program launched locally to ... room visits and hospital admissions among participants. , ... Diabetes Checks & Balances encourages people with diabetes ... tests, including HbA1c (a test indicating the level ...
Cached Medicine News:Health News:Has Hollywood's Diet Obsession Forced the US Government to Take Action? 2Health News:Has Hollywood's Diet Obsession Forced the US Government to Take Action? 3Health News:New HIV Infection Figures from CDC to be Announced on Aug. 3 Underscore Need for National AIDS Strategy for the U.S. 2Health News:Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2008 Earnings Release Date and Teleconference 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 3Health News:Innovative diabetes program in Bloomington-Normal, Ill., a success 2
Maumenee vitreous aspirating cannula, 18 gauge....
Reusable cannula with .90 mm (20 g) shaft, tapering to .30 mm (30 g). Angled 125 3 mm from tip and flattened for easy insertion into the subretinal space....
Reusable blunt cannula with luer hub. Cannula length is 32 mm....
... cannula allows atraumatic access through ... aspiration of subretinal fluids. ... end of cannula. Luer ... connection to a backflush handle ...
Medicine Products: